APLM
APOLLOMICS-A (APLM)
NASDAQ
$19.04-$3.79 (-16.61%)
Price as of Jun 23, 2026 4:34 PM EDT
  • N/A
    Market Cap
  • 327.53%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
8.5M
N/A
0
N/A
0
N/A
0
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
8.5M
N/A
0
N/A
0
N/A
0
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-5.5M
-77.49%
-24.6M
-28.15%
-34.2M
-3.56%
-35.5M
N/A
Depreciation and Amortization Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Operating Expenses
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Profit
N/A
N/A
N/A
N/A
N/A
N/A
976,000
N/A
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
0
N/A
0
N/A
0
N/A
0
N/A
Total Nonoperating Income and Expense
494,000
-66.82%
1.5M
+22.35%
1.2M
-15.89%
1.4M
N/A
Income before Taxes
-10.9M
-79.69%
-53.9M
-68.80%
-172.6M
-28.33%
-240.8M
N/A
Income Taxes
3,000
-98.84%
259,000
+2,490.00%
10,000
+900.00%
1,000
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-10.9M
-79.69%
-53.9M
-68.80%
-172.6M
-28.33%
-240.8M
N/A
Net Income from Continuing Operations Applicable to Common
-10.9M
-79.69%
-53.9M
-68.80%
-172.6M
-28.33%
-240.8M
N/A
Basic EPS and Net Income
-7.57
-85.66%
-52.80
+2,175.86%
-2.32
+274.19%
-0.62
N/A
Diluted EPS and Net Income
-7.57
-85.66%
-52.80
+2,175.86%
-2.32
+274.19%
-0.62
N/A
Basic Weighted Average Shares
1.4M
+41.76%
1.0M
-98.63%
74.4M
-80.97%
390.9M
N/A
Diluted Weighted Average Shares
1.4M
+41.76%
1.0M
-98.63%
74.4M
-80.97%
390.9M
N/A
Balance Sheet
Cash and Cash Equivalents
3.3M
-66.46%
9.8M
-69.53%
32.1M
-1.89%
32.7M
N/A
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
3.3M
-66.46%
9.8M
-69.53%
32.1M
-1.89%
32.7M
N/A
Total Current Assets
6.1M
-41.06%
10.3M
-74.28%
39.9M
-28.44%
55.8M
N/A
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
3,000
-96.74%
92,000
-42.86%
161,000
-66.80%
485,000
N/A
Total Long-Term Assets
663,000
-76.58%
2.8M
-81.69%
15.5M
-25.25%
20.7M
N/A
Total Assets
6.7M
-48.74%
13.1M
-76.35%
55.4M
-27.58%
76.5M
N/A
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
80.0M
N/A
0
-100.00%
4.2M
N/A
N/A
N/A
Total Current Liabilities
6.3M
-14.50%
7.4M
-45.42%
13.6M
+9.70%
12.4M
N/A
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
3.6M
+328.26%
835,000
+39.87%
597,000
-99.88%
512.2M
N/A
Total Liabilities
511.9M
0.00%
511.9M
0.00%
511.9M
+14.22%
448.1M
N/A
Retained Earnings
-711.8M
+1.56%
-700.8M
+8.32%
-647.0M
+36.32%
-474.6M
N/A
Total Stockholders Equity
-3.2M
-165.54%
4.9M
-88.20%
41.2M
+109.20%
-448.1M
N/A
Total Shares Outstanding
2.1M
+94.70%
1.1M
-65.07%
3.2M
-99.23%
408.7M
N/A
Cash Flow
Cash from Operating Activities
-10.4M
-63.93%
-28.7M
-33.48%
-43.2M
+0.90%
-42.8M
N/A
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
218,000
-96.36%
6.0M
-72.00%
21.4M
-26.46%
29.1M
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
3.7M
+685.47%
468,000
-97.80%
21.2M
+7,319.39%
-294,000
N/A
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
-110.43%
-29.79%
-157.28%
-39.92%
-261.79%
N/A
N/A
N/A
Return on Equity
-1,305.37%
+458.64%
-233.67%
-375.42%
84.84%
N/A
N/A
N/A
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
0.96
-31.07%
1.39
-52.89%
2.95
N/A
N/A
N/A
Cash Ratio
0.52
-60.76%
1.32
-44.18%
2.36
N/A
N/A
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow